Transforming the workers’ compensation pharmacy and ancillary benefits management experience

Powered by state-of-the-art technology
Supported by human-centered service
Informed by industry expertise
Inspired by a commitment to care
women with a migraine post image
blog

Novel Migraine Agents: What is Their Place in Injured Worker Therapy?

While these drugs offer relief for migraine sufferers, what are the efficacy and cost considerations for injured workers?
Read More
rxinformer

Ask a Clinician: What Do I need to Know About DME Trends?

Healthesystems clinicians tackle questions about Durable Medical Equipment (DME).
Read More
MAC Monitor and magazine cover graphic
INDUSTRY SURVEY

2024 Industry Survey Report

This sixth annual survey report highlights the top challenges and priorities of 500 industry professionals.
Read More

Featured Videos

Personalize my experience

Make selections below to see articles and information related to your role and interests.
  • I am a

  • I'm interested in

DEA to Improve Access to Marijuana Research

Proposed changes to who can grow and research marijuana will soon be available for public commentary.

Sep 2019

Johnson & Johnson to Pay $572 Million in Opioid Trial

An Oklahoma judge found the drug maker to be partially responsible for the harm of the opioid epidemic.

Sep 2019

Three Insights from WOHC 2019

Healthesystems’ Chief Medical Officer explores trends impacting workers’ comp, including patient engagement, population health, and more.

Sep 2019

FDA Approves First Lyrica Generics

Nine generic versions of Lyrica (pregabalin) have been approved for the treatment of five different medical conditions.

Aug 2019

Healthesystems AVP of Advocacy & Compliance Named Finalist for Comp Laude Award

Sandy Shtab has been recognized for making significant contributions to the workers’ comp industry.

Aug 2019

FAIR Health Publishes Telemedicine Report

Looking at over 29 billion private health claims, this study found that claim lines related to telehealth rose 624% from 2014-2018.

Aug 2019

WCRI Reports on Interstate Variation in Dispensing Opioids

While many states report fewer opioid prescriptions, MME levels vary more significantly by state.

Aug 2019

Will Autonomous Vehicles Impact Workers’ Comp?

NCCI estimates that a 25-75% reduction in motor vehicle accidents in workers’ comp could save $1-4 billion, creating interest in self-driving cars.

Aug 2019

First-Time Generics Approved for Two Pain Medications

Generic versions of Ultram (tramadol hydrochloride) tablets and Dyloject (diclofenac sodium) injections have been approved by the FDA.

Jul 2019

NCCI Examines Impact of the ODG Formulary in Arizona and Tennessee

While the utilization of opioids and other problematic drugs decreased, similar drops were seen in states without closed formularies.

Jul 2019

Healthesystems Product Owner Receives IAIABC NextGen Award

Stephanie Arkelian has been recognized as a talented young professional making a positive impact on the workers’ comp industry.

Jul 2019

New York City and Nevada Prohibit Hiring Discrimination for Positive Marijuana Tests

Beyond exceptions for safety or federal positions, employers cannot refuse employment for testing positive for marijuana in pre-employment drug screenings.

Jul 2019

Marijuana Laws No Longer Thought to Reduce Opioid Overdose Deaths

A new study builds upon earlier research with a larger, more up-to-date dataset, finding a reversal in trends.

Jul 2019

Healthesystems at WCI Orlando 2019

Visit Healthesystems in booth #909 and learn how we’re making waves in workers’ comp, and how we hope to benefit coastal cleanups for the “Coast to Coast” theme.

Jul 2019

Top Challenges

What do you see as the biggest challenge for your workers’ comp program in 2019 and beyond?

2019 Workers' Comp Industry Insights Survey

Major Trends

What industry trend do you think will have the biggest impact on your workers’ comp program in the next year?

2019 Workers' Comp Industry Insights Survey

Program Priorities

Rank the below items in order of priority for your organization’s workers’ comp program.

2019 Workers' Comp Industry Insights Survey

Program Successes

What workers’ comp program has your organization implemented that you’re finding the most success with?

2019 Workers' Comp Industry Insights Survey

FDA Reexamines Discontinued Drug for New Pain Applications

Orphengesic Forte has received a decision date of August 14, 2019.

Jun 2019

Shifting Gears in Patient Transportation with Rideshare

How services like Lyft and Uber can amplify injured worker transportation programs to improve claims outcomes.

Jun 2019

The Growing Utilization and Costs of Anticancer Medications

Though they’re only needed for special cases in workers’ comp, anticancer medications can easily exceed $10,000 per monthly fill.

Jun 2019


First Public Hearing for Cannabidiol (CBD) Products

Though most forms of marijuana are highly regulated, CBD products are readily available across the country. What does this mean for healthcare?

Jun 2019

FDA Proposes Fixed-Quantity Blister Packaging for Certain Opioids

In a call for public comment, the FDA believes that reducing excess opioid supplies can lower opioid misuse, abuse, and overdose.

Jun 2019

FDA Approves First Generic Naloxone Nasal Spray for Opioid Overdose

The life saving antidote for opioid overdose will soon be available in a consumer-friendly, generic nasal spray.

May 2019

2019 Workers’ Comp Industry Insights Survey

Healthesystems partnered with Risk & Insurance magazine to survey 500+ work comp professionals on their top challenges, trends, successes, and more.

May 2019

Negative Impacts of Combining Antidepressants with Opioids and Benzodiazepines

Combining all three drugs can reduce claim closure rates to 58.3%, with average claim costs of $94,000.

May 2019

Growing Trend: Expanding Cancer Coverage for Firefighters

Florida enacted a law to cover 21 different cancers, while other states like Montana, Maryland, and Virginia have recently passed similar laws.

May 2019

National Institute of Health to Launch $350 Million Opioid Intervention Study

Four research sites will test proven opioid prevention and treatment interventions, hoping to reduce overdose deaths by 40% over three years.

May 2019

FDA Tightens Restrictions for Transmucosal Fentanyl Products

New changes to REMS safety programs will require stronger treatment documentation and oversight.

Apr 2019

Patient Engagement is Personal: How to Help Injured Workers Help Themselves

Patient engagement can lead to better health outcomes, but not all engagement strategies are equally effective.

Apr 2019

1 2 3 4 5 14 15 16 17 18 19 20
lockenvelopephone-handsetmagnifiermenuarrow-rightcross-circle